Corporate Governance
Code of Business Conduct and Ethics
Overview
MediCard Philippines, Inc. (MPI) is dedicated to doing business in accordance with the highest standards of ethics. MPI, its directors, officers and employees endeavour to promote a culture of good corporate governance by observing and maintaining its core business principles of accountability, integrity, fairness and transparency in their relationships among themselves and with MPI’s customers, suppliers, competitors, business partners, government, regulators and the public.
MediCard has consistently affirmed its commitment and fidelity to its values and to doing things the right way including decisions and actions when performing duties and responsibilities.
All directors, the management and employees of MPI are required to comply to MediCard’s Code of Discipline and Conduct.
Corporate Governance Manual
Overview
The Board of Directors and Management, i.e., officers and staff, of MediCard Philippines, Inc. is committed to maintaining high standards of corporate governance. We believe that effective corporate governance is essential to the company and establishes an open and transparent framework for delivering services to our members and clients.
The Corporate Governance Manual aims to assist the members of the Company’s various boards and committees in the exercise of their responsibilities to serve the best interests of the company and its members and clients. These guidelines are intended to ensure that the members of the boards and committees will be better able to review and evaluate the business operations and to make appropriate decisions as needed. It is a necessary component of sound strategic business management and will, therefore, undertake every effort necessary to create awareness within the organization to ensure that the principles of fairness, accountability and transparency are indispensable in conducting the day-to-day business of the Company.
Corporate Policies
Policy On Board Diversity
Policy On Board Nomination And Election
Policy On Retirement Of Directors
Policy On Succession Planning And Remuneration
Policy On Training For Board Of Directors
Policy On Related Party Transactions
Policy On Whistle Blowing
Policy On Board Performance Assessment
Policy On Conflict Of Interest
Enterprise Risk Management Framework
Overview
The Company recognizes the increasing importance of sound risk management practices to drive business growth and sustainability. The Company implemented systems and processes to facilitate proper risk identification, monitoring and control, which are key to effective corporate governance. Timely and accurate management and financial reporting systems, internal controls, and audits are also employed to protect and maximize stakeholders’ value.
The Board oversees Management’s adoption and implementation of a sound risk management framework for identifying, monitoring and managing key risk areas. The Board of Directors reviews Management reports with due diligence to enable the company to anticipate, minimize, control and manage risks or possible threats to its operational and financial viability.
Annual Corporate Governance Report
Overview
The Board and management of MediCard Philippines, Inc. firmly believe that commitment to good corporate governance is essential to the sustainability of the Company’s business and performance.
In compliance with the requirements of the Insurance Commission under IC Circular Letter No. 2020-72 dated 13 June 2020, MediCard filed and made public its Annual Corporate Governance Report (ACGR).
Annual Corporate Governance Report 2024
Source Documents
- MediCard Corporate Governance Policy and Procedure Manual
- 2024 MediCard Annual Report
- 2024 ESG Report
- Policy on Board Diversity
- Board Charter
- Audit and Related Party Transaction (RPT) Committee Charter
- Corporate Governance Committee Charter
- Board Risk Committee Charter
- Policy on Board Performance Assessment
- Policy on the Retirement of Directors and Officers
- Code of Business Conduct and Ethics
- Policy on Related Party Transactions
- Policy on Whistle Blowing
- Minutes of the 2024 Annual Stockholders' Meeting
- Policy on Board Nomination and Election
Annual Corporate Governance Report 2023
Source Documents
- Anti-Corruption Policy
- Annual Report 2023 with Audited Financial Statements
- Annual Stockholders’ Meeting Minutes for 2023
- Audit and Related Party Transaction (RPT) Committee Charter
- Board Charter
- Board Risk Committee Charter
- Code of Business Conduct and Ethics
- Corporate Governance Committee Charter
- Enterprise Risk Management Framework
- ESG Report 2023 of the comprehensive ESG Report for the AIA Group which includes MEDICARD
- Internal Audit Charter
- MediCard Corporate Governance Policy and Procedure Manual
- Policy on Board Diversity
- Policy on Board Nomination and Election
- Policy on Succession Planning and Remuneration
- Policy on Board Performance Assessment with the Board of Directors Self-Assessment Questionnaire
- Policy on Related Party Transactions
- Policy on Retirement of Directors
- Policy on Whistle Blowing
Annual Corporate Governance Report 2022
Annual Corporate Governance Report 2021
Annual Corporate Governance Report 2020
Code of Business Conduct and Ethics
Overview
MediCard Philippines, Inc. (MPI) is dedicated to doing business in accordance with the highest standards of ethics. MPI, its directors, officers and employees endeavour to promote a culture of good corporate governance by observing and maintaining its core business principles of accountability, integrity, fairness and transparency in their relationships among themselves and with MPI’s customers, suppliers, competitors, business partners, government, regulators and the public.
MediCard has consistently affirmed its commitment and fidelity to its values and to doing things the right way including decisions and actions when performing duties and responsibilities.
All directors, the management and employees of MPI are required to comply to MediCard’s Code of Discipline and Conduct.
Corporate Governance Manual
Overview
The Board of Directors and Management, i.e., officers and staff, of MediCard Philippines, Inc. is committed to maintaining high standards of corporate governance. We believe that effective corporate governance is essential to the company and establishes an open and transparent framework for delivering services to our members and clients.
The Corporate Governance Manual aims to assist the members of the Company’s various boards and committees in the exercise of their responsibilities to serve the best interests of the company and its members and clients. These guidelines are intended to ensure that the members of the boards and committees will be better able to review and evaluate the business operations and to make appropriate decisions as needed. It is a necessary component of sound strategic business management and will, therefore, undertake every effort necessary to create awareness within the organization to ensure that the principles of fairness, accountability and transparency are indispensable in conducting the day-to-day business of the Company.
Corporate Policies
Policy On Board Diversity
Policy On Board Nomination And Election
Policy On Retirement Of Directors
Policy On Succession Planning And Remuneration
Policy On Training For Board Of Directors
Policy On Related Party Transactions
Policy On Whistle Blowing
Policy On Board Performance Assessment
Policy On Conflict Of Interest
Enterprise Risk Management Framework
Overview
The Company recognizes the increasing importance of sound risk management practices to drive business growth and sustainability. The Company implemented systems and processes to facilitate proper risk identification, monitoring and control, which are key to effective corporate governance. Timely and accurate management and financial reporting systems, internal controls, and audits are also employed to protect and maximize stakeholders’ value.
The Board oversees Management’s adoption and implementation of a sound risk management framework for identifying, monitoring and managing key risk areas. The Board of Directors reviews Management reports with due diligence to enable the company to anticipate, minimize, control and manage risks or possible threats to its operational and financial viability.
Annual Corporate Governance Report
Overview
The Board and management of MediCard Philippines, Inc. firmly believe that commitment to good corporate governance is essential to the sustainability of the Company’s business and performance.
In compliance with the requirements of the Insurance Commission under IC Circular Letter No. 2020-72 dated 13 June 2020, MediCard filed and made public its Annual Corporate Governance Report (ACGR).
Annual Corporate Governance Report 2024
Source Documents
- MediCard Corporate Governance Policy and Procedure Manual
- 2024 MediCard Annual Report
- 2024 ESG Report
- Policy on Board Diversity
- Board Charter
- Audit and Related Party Transaction (RPT) Committee Charter
- Corporate Governance Committee Charter
- Board Risk Committee Charter
- Policy on Board Performance Assessment
- Policy on the Retirement of Directors and Officers
- Code of Business Conduct and Ethics
- Policy on Related Party Transactions
- Policy on Whistle Blowing
- Minutes of the 2024 Annual Stockholders’ Meeting
- Policy on Board Nomination and Election
Annual Corporate Governance Report 2023
Source Documents
- Anti-Corruption Policy
- Annual Report 2023 with Audited Financial Statements
- Annual Stockholders’ Meeting Minutes for 2023
- Audit and Related Party Transaction (RPT) Committee Charter
- Board Charter
- Board Risk Committee Charter
- Code of Business Conduct and Ethics
- Corporate Governance Committee Charter
- Enterprise Risk Management Framework
- ESG Report 2023 of the comprehensive ESG Report for the AIA Group which includes MEDICARD
- Internal Audit Charter
- MediCard Corporate Governance Policy and Procedure Manual
- Policy on Board Diversity
- Policy on Board Nomination and Election
- Policy on Succession Planning and Remuneration
- Policy on Board Performance Assessment with the Board of Directors Self-Assessment Questionnaire
- Policy on Related Party Transactions
- Policy on Retirement of Directors
- Policy on Whistle Blowing
